NCT00467779 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Study of GDC-0973/XL518 in Patients With Solid Tumors


Sponsors: Genentech Hoffmann-La Roche	Phases: Phase I
Indications	Acronym:
Solid Cancers
Age Groups: Adult Senior	Gender: Both
Names: Drug: GDC-0973/XL518	Enrollment: 90

Additional information about NCT00467779.